Papers

WELCOME TO이화여대 AI-사회약학규제과학 연구실

Publications

Papers

> Publications > Papers

Papers
번호	제목
22	[2025] Economic Evaluation of Rituximab Versus Corticosteroid-Cyclophosphamide or Cyclosporine in Patients With Membranous Nephropathy in Republic of Korea
21	[2025] Incidence and risk of drug-induced interstitial lung disease associated with anti-neoplastic drugs
20	[2025] Risk of Alzheimer’s disease and Parkinson’s disease following androgen deprivation therapy in a real world nationwide cohort
19	[2025] A multicenter micro-costing analysis of flexible cystoscopic procedures in Korea
18	[2025] Assessing the Risk of Cognitive Impairment associated with Androgen Receptor Targeting Agent Use in Metastatic Prostate Cancer: A Systematic Review of Real-world Data
17	[2025] COVID-19 infection in patients with end-stage kidney disease undergoing renal replacement therapies in Korea
16	[2025] Clinician guidance in digital therapeutics for panic disorder: Meta-analytic dissection and implications for regulatory framing and scalable deployment
15	[2025] Cost-Effectiveness of Tailored vs. Empirical Therapy for H. pylori: A Decision-Tree Analysis
14	[2025] Economic Evaluation of Rituximab Versus Corticosteroid-Cyclophosphamide or Cyclosporine in Patients With Membranous Nephropathy in Republic of Korea
13	[2025] Incidence and risk of drug-induced interstitial lung disease associated with anti-neoplastic drugs
12	[2025] Insignificant difference in medication adherence to dyslipidemia drugs between visually impaired and non-disabled people in South Korea: A nationwide cohort study using claims records
11	[2025] Oral Branched-Chain Amino Acids as a Cost-Effective Option for Managing Hepatic Encephalopathy
10	[2025] Prescription trends of gastric acid suppressants and association with potential adverse events in Korea: a real-world cross-sectional study
9	[2025] Risk of Alzheimer's disease and Parkinson's disease following androgen deprivation therapy in a real world nationwide cohort
8	[2025] Self-testing strategy to eliminate hepatitis C as per World Health Organization's goal: Analysis of disease burden and cost-effectiveness
7	[2025] 수원시 거주자의 혈압 및 혈당 인지율의 지역 간 격차와 관련 요인
6	[2024] Cost-effectiveness Analysis of COMT-inhibitors as Adjuvant Treatments to Levodopa in Patients with Advanced Parkinson's Disease
5	[2024] Determinants of immune checkpoint inhibitor use and factors linked to neurological adverse events in Korean lung cancer
4	[2024] Expert survey on real-world data utilization and real-world evidence generation for regulatory decision-making in drug lifecycle in Korea
3	[2024] Kidney replacement therapy trends in end-stage kidney disease patients in South Korea during the COVID-19 pandemic
2	[2024] Recent updates on treatment patterns in patients with treated attention-deficit/hyperactivity disorders from a nationwide real-world database in South Korea INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
1	[2024] Unveiling the chasm of economic burden from metastatic prostate cancer through a nationwide retrospective cohort study